188 related articles for article (PubMed ID: 25688366)
1. Structure-function based molecular relationships in Ewing's sarcoma.
Todorova R
Biomed Res Int; 2015; 2015():798426. PubMed ID: 25688366
[TBL] [Abstract][Full Text] [Related]
2. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes.
Bertolotti A; Melot T; Acker J; Vigneron M; Delattre O; Tora L
Mol Cell Biol; 1998 Mar; 18(3):1489-97. PubMed ID: 9488465
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway.
Spahn L; Petermann R; Siligan C; Schmid JA; Aryee DN; Kovar H
Cancer Res; 2002 Aug; 62(16):4583-7. PubMed ID: 12183411
[TBL] [Abstract][Full Text] [Related]
4. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.
Kinsey M; Smith R; Lessnick SL
Mol Cancer Res; 2006 Nov; 4(11):851-9. PubMed ID: 17114343
[TBL] [Abstract][Full Text] [Related]
5. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
6. Disordered binding regions of Ewing's sarcoma fusion proteins.
Todorova R
Bioorg Khim; 2014; 40(1):20-30. PubMed ID: 25898720
[TBL] [Abstract][Full Text] [Related]
7. Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.
Ng KP; Potikyan G; Savene RO; Denny CT; Uversky VN; Lee KA
Proc Natl Acad Sci U S A; 2007 Jan; 104(2):479-84. PubMed ID: 17202261
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
9. An Interaction with Ewing's Sarcoma Breakpoint Protein EWS Defines a Specific Oncogenic Mechanism of ETS Factors Rearranged in Prostate Cancer.
Kedage V; Selvaraj N; Nicholas TR; Budka JA; Plotnik JP; Jerde TJ; Hollenhorst PC
Cell Rep; 2016 Oct; 17(5):1289-1301. PubMed ID: 27783944
[TBL] [Abstract][Full Text] [Related]
10. Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.
Kim S; Denny CT; Wisdom R
Mol Cell Biol; 2006 Apr; 26(7):2467-78. PubMed ID: 16537893
[TBL] [Abstract][Full Text] [Related]
11. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
12. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.
Petermann R; Mossier BM; Aryee DN; Khazak V; Golemis EA; Kovar H
Oncogene; 1998 Aug; 17(5):603-10. PubMed ID: 9704926
[TBL] [Abstract][Full Text] [Related]
14. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3.
Prieur A; Tirode F; Cohen P; Delattre O
Mol Cell Biol; 2004 Aug; 24(16):7275-83. PubMed ID: 15282325
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
[TBL] [Abstract][Full Text] [Related]
16. A transcription assay for EWS oncoproteins in Xenopus oocytes.
Ng KP; Cheung F; Lee KA
Protein Cell; 2010 Oct; 1(10):927-34. PubMed ID: 21204019
[TBL] [Abstract][Full Text] [Related]
17. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
[TBL] [Abstract][Full Text] [Related]
18. An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene.
Zhou H; Lee KA
Oncogene; 2001 Mar; 20(12):1519-24. PubMed ID: 11313895
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation by the Ewing's sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain.
Li KK; Lee KA
J Biol Chem; 2000 Jul; 275(30):23053-8. PubMed ID: 10767297
[TBL] [Abstract][Full Text] [Related]
20. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
